| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |